1 |
Details of the person discharging managerial responsibilities / person closely associated |
a) |
Name |
Mazen Darwazah |
2 |
Reason for the notification |
a) |
Position/status |
Executive Vice Chairman |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Release of a pledge by Darhold Limited over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%. |
c) |
Price(s) and volume(s) |
Price(s): £0.00p Volume(s): 1,800,000 |
d) |
Aggregated information |
Aggregated volume: 1,800,000 Price: £0.00p |
e) |
Date of the transaction |
4 June 2018 |
f) |
Place of the transaction |
Amman |